 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma |
| Hye Won Lee, Kyung Joo Cho, Soon Young Shin, Ha Yan Kim, Eun Ju Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han |
|
J Liver Cancer. 2019;19(2):108-116. Published online September 30, 2019 DOI: https://doi.org/10.17998/jlc.19.2.108 |
|
Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma Journal of Liver Cancer. 2019;19(2):108-116  Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients Journal of Hepatocellular Carcinoma. 2016;Volume 4:11-13 Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment Response . 2020; Identification and Validation a Costimulatory Molecule Gene Signature to Predict the Prognosis and Immunotherapy Response for Hepatocellular Carcinoma . 2021; Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma Frontiers in Genetics. 2022;12: Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection . 2019; Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection . 2019; Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection . 2019; Construction of a Six Immune-Related lncRNAs Signature to Predict Outcome, Immune Cell Infiltration and Immunotherapy Response in Patients with Hepatocellular Carcinoma . 2020; A Novel Immune‑Related Gene-Based Model: Prognosis and Immunotherapy Response in Hepatocellular Carcinoma . 2022; |
